| P50 | author | Todd C Knepper | Q61098374 |
| P2093 | author name string | Xiang Chen | |
| | Jie Liu | |
| | Yi Luo | |
| | Xu Zhang | |
| | Gang Huang | |
| | Howard L McLeod | |
| | Cong Peng | |
| | Liyang Zhang | |
| | Weili Wang | |
| | Weiqi Zeng | |
| | Yijing He | |
| | Zhengxiao Ouyang | |
| | Biaobo Xu | |
| | Chengfang Zhou | |
| | Ruohui He | |
| | Xian'an Li | |
| | Xuezheng Xu | |
| P2860 | cites work | Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib | Q24594790 |
| | Improved survival with vemurafenib in melanoma with BRAF V600E mutation | Q24631953 |
| | Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance | Q24645668 |
| | RAF inhibitors that evade paradoxical MAPK pathway activation | Q27702299 |
| | Inhibition of Mutated, Activated BRAF in Metastatic Melanoma | Q27860458 |
| | Copper is required for oncogenic BRAF signalling and tumorigenesis | Q28237892 |
| | In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors | Q28240436 |
| | Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial | Q29614756 |
| | COT drives resistance to RAF inhibition through MAP kinase pathway reactivation | Q29615032 |
| | Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases | Q33829284 |
| | The MAPK pathway across different malignancies: a new perspective | Q34459097 |
| | Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin | Q34646533 |
| | A randomized, controlled trial of oral propranolol in infantile hemangioma. | Q34668015 |
| | Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival | Q35640094 |
| | Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment | Q35640172 |
| | β2-adrenoceptor blockage induces G1/S phase arrest and apoptosis in pancreatic cancer cells via Ras/Akt/NFκB pathway | Q35650414 |
| | Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients | Q36084905 |
| | Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation | Q36440738 |
| | β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma. | Q36959073 |
| | Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression | Q37120838 |
| | Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma. | Q37649652 |
| | Mutant BRAF melanomas--dependence and resistance | Q37830845 |
| | Antiproliferative effects of β-blockers on human colorectal cancer cells. | Q38894715 |
| | Inhibition of human melanoma growth by a non-cardioselective β-blocker | Q38960825 |
| | Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice | Q39392805 |
| | Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via β-adrenergic receptor-dependent activation of P38/MAPK pathway | Q39454109 |
| | The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling | Q39636983 |
| | Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer | Q40059218 |
| | Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells | Q40213140 |
| | Costs, resource utilization, and treatment patterns for patients with metastatic melanoma in a commercially insured setting | Q40824114 |
| | Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial | Q40875359 |
| | Overexpression of Akt converts radial growth melanoma to vertical growth melanoma. | Q41825555 |
| | A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate | Q42229597 |
| | Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression | Q42434242 |
| | Acral melanoma: a unique disease in Asia | Q43800316 |
| | β-Blockers and metastasis in non-small-cell lung cancer | Q44119515 |
| | Propranolol induces apoptosis of human umbilical vein endothelial cells through downregulation of CD147. | Q45732085 |
| | Propranolol for severe hemangiomas of infancy. | Q46542573 |
| | In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. | Q48494604 |
| | Mitogen-actived protein kinase activation is an early event in melanoma progression. | Q53745580 |
| | Treatment With β-Blockers and Reduced Disease Progression in Patients With Thick Melanoma | Q59489502 |
| | Relationship between plasma propranolol concentration and dose in young, healthy volunteers | Q69507434 |
| P433 | issue | 42 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 68314-68327 | |
| P577 | publication date | 2016-10-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway | |
| P478 | volume | 7 | |